Labadie, Brian W <br/><br/>
Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  03 2019 
 - 1462-1471 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-18-2882  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line, Tumor<br/>Computational Biology--methods<br/>Enzyme Inhibitors--chemistry<br/>Gene Expression Profiling<br/>Humans<br/>Immunomodulation<br/>Immunotherapy<br/>Indoleamine-Pyrrole 2,3,-Dioxygenase--metabolism<br/>Kynurenine--metabolism<br/>Models, Biological<br/>Neoplasms--genetics<br/>Receptors, Aryl Hydrocarbon--metabolism<br/>Signal Transduction--drug effects<br/>Transcriptome<br/>Tryptophan--metabolism